QuadMedicine, Inc. (KOSDAQ:464490)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,170
-1,130 (-7.90%)
At close: Apr 2, 2026

QuadMedicine Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
26,50710,2634,449
Short-Term Investments
1,010--
Cash & Short-Term Investments
27,51710,2634,449
Cash Growth
168.12%130.69%-
Accounts Receivable
1,8031,10018.41
Other Receivables
393.823.220.23
Receivables
2,9741,10318.64
Prepaid Expenses
8.0586.89512.18
Other Current Assets
540.93232.9769.03
Total Current Assets
31,04011,6865,049
Property, Plant & Equipment
19,29919,75219,549
Long-Term Investments
-10-
Other Intangible Assets
597.95493.21364.21
Long-Term Accounts Receivable
-0-0-0
Other Long-Term Assets
242.17157.35257.19
Total Assets
51,17932,09825,219
Short-Term Debt
500500-
Current Portion of Long-Term Debt
5,90099.6-
Current Portion of Leases
283.22206.35295.71
Other Current Liabilities
4,1385,5243,616
Total Current Liabilities
10,8216,3303,912
Long-Term Debt
5516,4515,800
Long-Term Leases
249.76106.84327.7
Other Long-Term Liabilities
8,7597,6116,217
Total Liabilities
20,38020,49816,256
Common Stock
5,6714,6764,358
Additional Paid-In Capital
71,33845,48338,472
Retained Earnings
-48,619-41,688-36,720
Comprehensive Income & Other
2,4093,1282,853
Shareholders' Equity
30,79911,6008,963
Total Liabilities & Equity
51,17932,09825,219
Total Debt
7,4847,3636,423
Net Cash (Debt)
20,0332,899-1,975
Net Cash Growth
590.96%--
Net Cash Per Share
2086.82332.64-228.65
Filing Date Shares Outstanding
10.19.358.74
Total Common Shares Outstanding
10.19.358.74
Working Capital
20,2195,3561,137
Book Value Per Share
3049.491240.401025.97
Tangible Book Value
30,20111,1078,599
Tangible Book Value Per Share
2990.281187.66984.28
Land
2,1872,1871,951
Buildings
9,6839,6838,572
Machinery
10,9979,1307,681
Construction In Progress
317.24171.69555.41
Source: S&P Global Market Intelligence. Standard template. Financial Sources.